Drug profile · INN
afatinib maleate
GIOTRIF
afatinib maleate (GIOTRIF) is a epidermal growth factor receptor erbb1 inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — afatinib maleate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.78
Quick answer
afatinib maleate (GIOTRIF) is a epidermal growth factor receptor erbb1 inhibitor.
Key facts
INN afatinib maleate
Brand GIOTRIF
Mechanism Epidermal growth factor receptor erbB1 inhibitor
Target Epidermal growth factor receptor
Mechanism of action
Epidermal growth factor receptor erbB1 inhibitor
Primary target: Epidermal growth factor receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is afatinib maleate?
afatinib maleate (GIOTRIF) is a epidermal growth factor receptor erbb1 inhibitor.
What is the brand name for afatinib maleate?
GIOTRIF is a marketed brand name for afatinib maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.